Jincheng Pharm(SZ:300233)2022-12-08 05:28Group 1: Market Demand and Product Advantages - The domestic market for glutathione raw materials is primarily driven by formulations, with major domestic manufacturers now relying on local suppliers instead of imports [2][3] - The company has advantages over Japanese imports due to guaranteed product quality and technological upgrades [3][4] - The main barriers to glutathione products are fermentation and purification stages, particularly in strain cultivation [3] Group 2: Export Markets and Sales Proportions - The company exports to North America, Southeast Asia, and Europe, with products already present in over ten countries including the USA, Italy, Germany, and Brazil [3][4] - The sales ratio of glutathione products is approximately 60% domestic and 40% international [4][5] Group 3: Strategic Developments - The acquisition of Tianchen Pharmaceutical is aimed at adapting to the company's strategic transformation and extending its operations into downstream industries [5] - The company is conducting market research and planning for the sales of its newly approved "Yikang Peptide" product while maintaining communication with health product enterprises [4][5]